The data also shows the 10 countries most affected by climate...
Category:
Eco/Invest/Demography
Latest
In 2022 one-fourth of people living with diabetes in India Lancet study estimates
Of the 82.8 crore, India's share formed over a quarter (21.2...
World already on cusp of 1.5 degree celsius temp rise, finds new research
Every extra increment of heat risks worsening climate impacts like...
Floods may be nearly as important as droughts for future carbon accounting
“These wet extremes have basically been ignored in this field and we’re showing that researchers need to rethink it when designing schemes for future carbon accounting,” said senior study author Alexandra Konings, an assistant professor of Earth system science in Stanford’s School of Earth, Energy & Environmental Sciences (Stanford Earth). “Specific regions might be much more important for flood impacts than previously thought.”
Generation Equality: Alongside COVID lies an ‘equally horrific pandemic’ threatening women
And compared to men, women are 24 per cent more likely to lose their jobs and can expect their income to fall by 50 per cent more – making economic justice and rights imperative.
At the same time, women are 10 per cent less likely than men to have internet access, leaving 433 million women globally on “mute”.
India’s life insurance industry to reach $98.5bn in 2024, forecasts GlobalData
An analysis of GlobalData’s Global Insurance Database reveals that Indian life insurance industry is expected to grow at a compound annual growth rate (CAGR) of 7.0% over FY2019-2024, driven by favorable demographic factors, and economic recovery expected over the second half of 2021.
India’s Zydus Cadila seeks approval for its 3-dose COVID vaccine
Zydus said the efficacy result is based on an interim analysis of a late-stage trial of more than 28,000 volunteers nationwide, including nearly 1,000 subjects in the age group of 12 to 18.
Immunogenicity data for the adolescent children subset will be submitted in the next four to six weeks, Patel said.
Some European countries to allow travellers from India inoculated with Covishield – Indian govt sources
An Indian foreign ministry source said on Thursday that Austria, Germany, Slovenia, Greece, Iceland, Ireland, Spain and Switzerland had informed the Indian government that Covishield would be accepted for the purposes of travel.
Not much data on Delta plus variant to suggest it’s more infectious, causes more deaths: Delhi AIIMS director
“There isn’t much data on Delta plus variant to suggest it’s more infectious, causing more deaths, or has developed significant immune escape mechanism. But if we follow COVID appropriate behaviour and get vaccinated, we’ll be safe against any of emerging variants,” Dr Guleria told ANI.
WHO chief calls for vaccinating at least 10 per cent of population of every country by September
”Vast inequities in the access to vaccines are fuelling a two-track pandemic. While some countries have reached a high level of coverage, many others don’t have enough to vaccinate health workers, older people & other at-risk groups,” the World Health Organisation Director General said in a virtual address to India Global Forum.
‘Submit results on Covavax adult trials first’: Govt panel to SII on Covid-19 vaccine trials for children
“The Subject Expert Committee (SEC) recommended that the Pune-based company should submit the safety and immunogenicity data of Covavax from the ongoing trials in adults for considering the trials in children,” sources told ANI.
World must prepare for future crises by setting up Global Fund for Social Protection:UN expert
According to the International Labour Organisation (ILO), the majority of the world’s population — 55 percent, or 4 billion people — lacks any form of social protection. Another 16 percent, or 1.2 billion people, enjoy only partial protection. Only 35 percent of children, approximately one in three, benefit from child allowances that would ensure they receive childcare, nutrition and education.
J&J’s COVID-19 vaccine shows promise against Delta variant
“Current data for the eight months studied so far shows that the single-shot Johnson & Johnson COVID-19 vaccine generates a strong neutralizing antibody response that does not wane; rather, we observe an improvement over time,” Mathai Mammen, head of research & development at J&J’s drugs business, said in the statement.